COSCIENS Biopharma (CSCI) Total Assets

Annual Total Assets

$23.70 M
-$4.10 M-14.74%

December 1, 2023

Summary

Performance

1-Year Change

-14.74%

3-Year Change

+3.43%

5-Year Change

+27.49%

15-Year Change

+7.19%

CSCI Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

23.69%
CSCI annual total assets is higher than 23.69% of companies in Healthcare sector

High & Low

All-time High

$27.80 M
CSCI annual total assets is currently -14.74% below its historical high of $27.80 million

3-Year Low

$23.70 M
CSCI annual total assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CSCI previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CSCI next annual earnings announcement has not yet been scheduled

OtherCSCIbalance sheetmetrics:

Annual Current Assets

$36.37 M
CSCI annual total current assets is $36.37 million

Annual Non Current Assets

$649.00 K
CSCI annual long term assets is $649.00 thousand

Annual Total Liabilities

$2.71 M
CSCI annual total liabilities is $2.71 million

Annual Current Liabilities

$4.54 M
CSCI annual total current liabilities is $4.54 million

Quarterly Total Assets

$43.77 M
-$6.28 M-12.54%

September 1, 2024

Summary

Performance

3-Month Change

-12.54%

1-Year Change

+84.65%

3-Year Change

+84.65%

5-Year Change

+84.65%

CSCI Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.32%
CSCI quarterly total assets is higher than 32.32% of companies in Healthcare sector

High & Low

All-time High

$50.05 M
CSCI quarterly total assets is currently -12.54% below its historical high of $50.05 million

3-Year Low

$21.77 M
CSCI quarterly total assets is currently +101.09% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIbalance sheetmetrics:

Quarterly Current Assets

$28.22 M
CSCI quarterly total current assets is $28.22 million

Quarterly Non Current Assets

$15.55 M
CSCI quarterly long term assets is $15.55 million

Quarterly Total Liabilities

$23.75 M
CSCI quarterly total liabilities is $23.75 million

Quarterly Current Liabilities

$8.17 M
CSCI quarterly total current liabilities is $8.17 million

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

Annual Total Assets

$23.70 M
CSCI annual total assets is $23.70 million

Annual Non Current Assets

$649.00 K
CSCI annual long term assets is $649.00 thousand

Annual Current Assets

$36.37 M
CSCI annual total current assets is $36.37 million

CSCI Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-14.7%+84.7%
3 y3 years+3.4%+84.7%
5 y5 years+27.5%+84.7%

CSCI Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-14.7%at low-12.5%+101.1%
5 y5-year-14.7%+13.6%-12.5%+122.3%
alltimeall time-14.7%>+9999.0%-12.5%>+9999.0%

COSCIENS Biopharma Total Assets History

DateAnnualQuarterly
Sep 2024
-
$43.77 M(-12.5%)
Jun 2024
-
$50.05 M(+129.9%)
Mar 2024
-
$21.77 M(-8.2%)
Dec 2023
$23.70 M(-14.7%)
$23.70 M(-5.1%)
Sep 2023
-
$24.97 M(-4.0%)
Jun 2023
-
$26.02 M(-4.0%)
Mar 2023
-
$27.09 M(-2.6%)
Dec 2022
$27.80 M(+14.2%)
$27.80 M(+6.2%)
Sep 2022
-
$26.17 M(-3.0%)
Jun 2022
-
$26.98 M(+3.6%)
Mar 2022
-
$26.05 M(+7.0%)
Dec 2021
$24.35 M(+6.3%)
$24.35 M(-0.4%)
Sep 2021
-
$24.45 M(+0.6%)
Jun 2021
-
$24.30 M(+4.2%)
Mar 2021
-
$23.31 M(+1.7%)
Dec 2020
$22.92 M(+9.8%)
$22.92 M(+5.2%)
Sep 2020
-
$21.78 M(+2.9%)
Jun 2020
-
$21.17 M(+7.5%)
Mar 2020
-
$19.69 M(-5.7%)
Dec 2019
$20.88 M(+12.3%)
$20.88 M(+0.6%)
Sep 2019
-
$20.76 M(-0.4%)
Jun 2019
-
$20.84 M(-0.7%)
Mar 2019
-
$20.98 M(+12.8%)
Dec 2018
$18.59 M(-15.9%)
$18.59 M(-6.3%)
Sep 2018
-
$19.84 M(-4.7%)
Jun 2018
-
$20.82 M(-1.5%)
Mar 2018
-
$21.13 M(-4.4%)
Dec 2017
$22.11 M(+12.6%)
$22.11 M(+0.3%)
Sep 2017
-
$22.05 M(+6.1%)
Jun 2017
-
$20.78 M(+3.6%)
Mar 2017
-
$20.06 M(+2.2%)
Dec 2016
$19.64 M(+73.5%)
$19.64 M(-1.4%)
Sep 2016
-
$19.91 M(+48.2%)
Jun 2016
-
$13.43 M(+5.1%)
Mar 2016
-
$12.79 M(+13.0%)
Dec 2015
$11.32 M(+71.0%)
$11.32 M(+39.1%)
Sep 2015
-
$8.14 M(+5.5%)
Jun 2015
-
$7.71 M(+17.2%)
Mar 2015
-
$6.58 M(-0.6%)
Dec 2014
$6.62 M(+38.3%)
$6.62 M(+3.2%)
Sep 2014
-
$6.41 M(-4.5%)
Jun 2014
-
$6.72 M(+29.4%)
Mar 2014
-
$5.19 M(+8.4%)
Dec 2013
$4.79 M(+22.5%)
$4.79 M(+52.3%)
Sep 2013
-
$3.14 M(-4.4%)
Jun 2013
-
$3.29 M(-7.4%)
Mar 2013
-
$3.55 M(-9.1%)
Dec 2012
$3.91 M(-4.4%)
$3.91 M(-6.0%)
Sep 2012
-
$4.15 M(+13.6%)
Jun 2012
-
$3.66 M(-14.4%)
Mar 2012
-
$4.27 M(+4.6%)
Dec 2011
$4.08 M(+44.9%)
$4.08 M(+38.5%)
Sep 2011
-
$2.95 M(-7.9%)
Jun 2011
-
$3.20 M(-0.2%)
Mar 2011
-
$3.21 M(+13.9%)
Dec 2010
$2.82 M
$2.82 M(+0.9%)
DateAnnualQuarterly
Sep 2010
-
$2.79 M(+9.8%)
Jun 2010
-
$2.55 M(-8.2%)
Mar 2010
-
$2.77 M(+4.8%)
Dec 2009
$2.65 M(-2.0%)
$2.65 M(-13.5%)
Sep 2009
-
$3.06 M(+6.6%)
Jun 2009
-
$2.87 M(+12.5%)
Mar 2009
-
$2.55 M(-5.6%)
Dec 2008
$2.70 M(-41.7%)
$2.70 M(-15.9%)
Sep 2008
-
$3.21 M(-12.4%)
Jun 2008
-
$3.67 M(-10.1%)
Mar 2008
-
$4.08 M(-12.0%)
Dec 2007
$4.63 M(+161.8%)
$4.63 M(+3.3%)
Sep 2007
-
$4.48 M(-10.7%)
Jun 2007
-
$5.02 M(+145.4%)
Mar 2007
-
$2.05 M(+15.6%)
Dec 2006
$1.77 M(-15.0%)
$1.77 M(-0.5%)
Sep 2006
-
$1.78 M(-22.1%)
Jun 2006
-
$2.28 M(+5.0%)
Mar 2006
-
$2.17 M(+4.4%)
Dec 2005
$2.08 M(+45.8%)
$2.08 M(+60.4%)
Sep 2005
-
$1.30 M(-12.7%)
Jun 2005
-
$1.49 M(-3.2%)
Mar 2005
-
$1.54 M(+7.6%)
Dec 2004
$1.43 M(+47.6%)
$1.43 M(+45.8%)
Sep 2004
-
$980.40 K(-17.3%)
Jun 2004
-
$1.19 M(+24.3%)
Mar 2004
-
$954.20 K(-1.4%)
Dec 2003
$968.00 K(+136.2%)
$968.00 K(+16.9%)
Sep 2003
-
$828.00 K(+30.1%)
Jun 2003
-
$636.30 K(+19.7%)
Mar 2003
-
$531.50 K(+29.7%)
Dec 2002
$409.90 K(+74.8%)
$409.90 K(+14.9%)
Sep 2002
-
$356.60 K(-11.9%)
Jun 2002
-
$404.60 K(+50.9%)
Mar 2002
-
$268.10 K(+14.3%)
Dec 2001
$234.50 K(+19.5%)
$234.50 K(-19.2%)
Sep 2001
-
$290.40 K(-0.8%)
Jun 2001
-
$292.70 K(+8.0%)
Mar 2001
-
$271.00 K(+38.1%)
Dec 2000
$196.20 K(-2.5%)
$196.20 K(-46.0%)
Sep 2000
-
$363.10 K(+7.6%)
Jun 2000
-
$337.60 K(+22.6%)
Mar 2000
-
$275.40 K(+36.9%)
Dec 1999
$201.20 K(-38.1%)
$201.20 K(-40.9%)
Sep 1999
-
$340.50 K(+0.4%)
Jun 1999
-
$339.20 K(-14.7%)
Mar 1999
-
$397.60 K(+22.3%)
Dec 1998
$325.00 K(-96.4%)
$325.00 K(-92.5%)
Sep 1998
-
$4.32 M(-51.5%)
Jun 1998
-
$8.92 M(-1.9%)
Mar 1998
-
$9.09 M(-0.7%)
Dec 1997
$9.15 M(-32.6%)
$9.15 M(-63.5%)
Sep 1997
-
$25.05 M(-1.2%)
Jun 1997
-
$25.35 M(-22.9%)
Mar 1997
-
$32.90 M
Dec 1996
$13.57 M
-

FAQ

  • What is COSCIENS Biopharma annual total assets?
  • What is the all time high annual total assets for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual total assets year-on-year change?
  • What is COSCIENS Biopharma quarterly total assets?
  • What is the all time high quarterly total assets for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly total assets year-on-year change?

What is COSCIENS Biopharma annual total assets?

The current annual total assets of CSCI is $23.70 M

What is the all time high annual total assets for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual total assets is $27.80 M

What is COSCIENS Biopharma annual total assets year-on-year change?

Over the past year, CSCI annual total assets has changed by -$4.10 M (-14.74%)

What is COSCIENS Biopharma quarterly total assets?

The current quarterly total assets of CSCI is $43.77 M

What is the all time high quarterly total assets for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly total assets is $50.05 M

What is COSCIENS Biopharma quarterly total assets year-on-year change?

Over the past year, CSCI quarterly total assets has changed by +$20.06 M (+84.65%)